Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6
暂无分享,去创建一个
F. He | Xiaohong Fu | Meng-gang Liu | X. Lyu | Gang Huang | D. Zhong | P. Xie
[1] L. Zhou,et al. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer. , 2020, European review for medical and pharmacological sciences.
[2] Hao Yang,et al. Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3 , 2020, Biotechnology Letters.
[3] R. Safaralizadeh,et al. MicroRNA replacement therapy in cancer , 2019, Journal of cellular physiology.
[4] Wei-Quan Xie,et al. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism. , 2019, American journal of physiology. Gastrointestinal and liver physiology.
[5] H. Chi,et al. MiR-124-3p suppresses glioma aggressiveness via targeting of Fra-2. , 2018, Pathology, research and practice.
[6] A. Irimie,et al. The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases , 2018, International journal of molecular sciences.
[7] L. Pang,et al. Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma , 2018, Molecular Biology Reports.
[8] F. Dai,et al. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation , 2018, Cell cycle.
[9] P. He,et al. Long non-coding RNA OGFRP1 regulates LYPD3 expression by sponging miR-124-3p and promotes non-small cell lung cancer progression. , 2018, Biochemical and biophysical research communications.
[10] Hui-Xiong Xu,et al. The Role of MicroRNAs in Hepatocellular Carcinoma , 2018, Journal of Cancer.
[11] F. Liu,et al. miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer , 2018, Biomedical reports.
[12] Bo Zhang,et al. Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation , 2018, Molecular Cancer.
[13] Xingjun Guo,et al. Tumor LXR Expression is a Prognostic Marker for Patients with Hepatocellular Carcinoma , 2018, Pathology & Oncology Research.
[14] Gang Chen,et al. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study , 2018, Oncology letters.
[15] Yanting Shi,et al. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma , 2018, Cell Death & Disease.
[16] J. Teng,et al. miR-124 promotes proliferation and differentiation of neuronal stem cells through inactivating Notch pathway , 2017, Cell & Bioscience.
[17] Kun Huang,et al. Glyceraldehyde‐3‐phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase , 2017, Hepatology.
[18] F. He,et al. Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells , 2017, Oncotarget.
[19] Guanghui Wang,et al. miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4 , 2017, OncoTargets and therapy.
[20] Luonan Chen,et al. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison , 2016, Scientific Reports.
[21] X. Chen,et al. miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL , 2016, BMC Cancer.
[22] Zhikun Zhang,et al. HuR‐regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer , 2016, Cancer medicine.
[23] Qiaobing Huang,et al. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells. , 2016, American journal of physiology. Cell physiology.
[24] Xin Chen,et al. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway , 2015, Gut.
[25] A. Guarini,et al. Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? , 2015, Expert opinion on therapeutic targets.
[26] J. Gustafsson,et al. Targeting liver X receptors in cancer therapeutics , 2015, Nature Reviews Cancer.
[27] T. Welling,et al. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. , 2014, Gastroenterology.
[28] W. Gong,et al. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells , 2014, Oncogene.
[29] R. Xu,et al. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. , 2012, The American journal of pathology.
[30] Thomas D. Schmittgen,et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. , 2011, Cancer research.
[31] X. Bian,et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 , 2011, Gut.
[32] D. Brown,et al. The promise of microRNA replacement therapy. , 2010, Cancer research.
[33] S. Cheung,et al. Hep G2 is a hepatoblastoma-derived cell line. , 2009, Human pathology.
[34] A. Katz,et al. Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR‐623, a Novel Liver X‐Receptor Agonist, in Healthy Participants , 2009, Journal of clinical pharmacology.
[35] Y. Shin,et al. Liver X receptor mediates hepatitis B virus X protein–induced lipogenesis in hepatitis B virus–associated hepatocellular carcinoma , 2009, Hepatology.
[36] R. Vibhakar,et al. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma , 2008, Journal of Neuro-Oncology.
[37] T. Maniatis,et al. Multilevel Regulation of Gene Expression by MicroRNAs , 2008, Science.
[38] Krista A. Zanetti,et al. Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.
[39] Timothy M Willson,et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. , 2002, Journal of medicinal chemistry.
[40] D. Mangelsdorf,et al. Role of LXRs in control of lipogenesis. , 2000, Genes & development.
[41] J. Pines,et al. Cyclins and cyclin-dependent kinases: a biochemical view. , 1995, The Biochemical journal.
[42] Bin Liu,et al. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer. , 2019, Cancer biomarkers : section A of Disease markers.
[43] Xin Chen,et al. MicroRNA-206 Prevents the Pathogenesis of Hepatocellular Carcinoma Via Modulating Expression of cMet and Cdk 6 , 2017 .
[44] A. Hampl,et al. Temporal Distribution of CDK4, CDK6, D-Type Cyclins, and p27 in Developing Mouse Oocytes1 , 2004, Biology of reproduction.
[45] D. Mangelsdorf,et al. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. , 2000, Annual review of cell and developmental biology.